Nucleome Therapeutics Limited
Biotechnology company · Oxford, England, United Kingdom
Nucleome Therapeutics Limited is a biotechnology company headquartered in Oxford, England, United Kingdom. Its earliest recorded incorporation is in 2019. It is registered with UK Companies House under company number 12109297.
Profile compiled from public records. Is this your company? Request a correction or update
Nucleome Therapeutics at a glance
Typebiotechnology company
HeadquartersOxford, England, United Kingdom
Earliest incorporation on record2019
Registered activities (UK)Research and experimental development on biotechnology
UK company number12109297
Frequently asked questions about Nucleome Therapeutics
Where is Nucleome Therapeutics headquartered?
Nucleome Therapeutics Limited is headquartered in Oxford, England, United Kingdom.
What does Nucleome Therapeutics do?
Nucleome Therapeutics Limited is a biotechnology company.
When was Nucleome Therapeutics founded?
The earliest incorporation on record for Nucleome Therapeutics Limited is in 2019, according to public company registers.
Similar companies
- Blue Earth Diagnostics LimitedOxford, England, United Kingdom
- Circassia IncOxford, England, United Kingdom
- Scancell LimitedOxford, England, United Kingdom
- Genomics LimitedOxford, England, United Kingdom
- Oxford Biotherapeutics LtdOxford, England, United Kingdom
- Sitryx Therapeutics LimitedOxford, England, United Kingdom
- Spybiotech LimitedOxford, England, United Kingdom
- Omass Therapeutics LimitedOxford, England, United Kingdom
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences